{"url_path":"/register/2026-07-08/2026-13810","section_key":"summary","section_title":"Cellular, Tissue, and Gene Therapies Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Biologics License Application (BLA) 125827, From Replimune, Inc. for Vusolimogene Oderparepvec","topic":"register","document":{"doc_type":"Notice","doc_date":"2026-07-08","source_url":"https://www.federalregister.gov/documents/2026/07/08/2026-13810/cellular-tissue-and-gene-therapies-advisory-committee-notice-of-meeting-establishment-of-a-public","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"Health and Human Services Department"},"word_count":105,"has_tables":false,"body_markdown":null}